FDA NDC Directory · JSON-LD · Markdown

Sulindac

NDC 55289-930 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerPD-Rx Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA071795
Dosage form / routeTABLET · ORAL
Active ingredientsSULINDAC (200 mg/1)
Marketing started19900403
Package count3

External sources

Source: openFDA. Public-domain (CC0).